Post-traumatic Syringomyelia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-04-05
Clinical Trial Update: Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia [Phase 2]
A Phase 2 trial assessing the efficacy of the cell therapy medicine NC1 in patients with post-traumatic syringomyelia has completed.